Notice2024-17793
Agency Information Collection Activities; Proposed Collection; Risk/Safety Considerations and Motivations for Purchase and Use of Kratom and Psychedelics Alone and in Combination With Other Substances; Withdrawal of Notice
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 12, 2024
Issuing agencies
Health and Human Services DepartmentFood and Drug Administration
Abstract
The Food and Drug Administration (FDA) is announcing the withdrawal of a notice that was published in the Federal Register of August 2, 2024.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 155 (Monday, August 12, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 155 (Monday, August 12, 2024)]
[Notices]
[Page 65635]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-17793]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2024-N-1532]
Agency Information Collection Activities; Proposed Collection;
Risk/Safety Considerations and Motivations for Purchase and Use of
Kratom and Psychedelics Alone and in Combination With Other Substances;
Withdrawal of Notice
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; withdrawal.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the
withdrawal of a notice that was published in the Federal Register of
August 2, 2024.
DATES: The notice is withdrawn on August 12, 2024.
FOR FURTHER INFORMATION CONTACT: Darren Eicken, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, Rm. 6206, Silver Spring, MD 20993-0002, 240-
402-0978.
SUPPLEMENTARY INFORMATION: In a notice published in the Federal
Register of August 2, 2024 (89 FR 63202), ``Agency Information
Collection Activities; Proposed Collection; Comment Request: Risk/
Safety Considerations and Motivations for Purchase and Use of Kratom
and Psychedelics Alone and in Combination With Other Substances,'' FDA
requested comment on the information collection associated with the
proposed study entitled ``Risk/Safety Considerations and Motivations
for Purchase and Use of Kratom and Psychedelics Alone and in
Combination With Other Substances.''
Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies
are required to publish notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
of an existing collection of information, and to allow 60 days for
public comment in response to the notice.
In the August 2, 2024, Federal Register notice, FDA proposed a new
collection of information. However, FDA no longer intends to proceed
with the proposed study as described because circumstances occurred
necessitating changes to the scope of the study. Therefore, we are
withdrawing the August 2, 2024, notice.
Dated: August 6, 2024.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2024-17793 Filed 8-9-24; 8:45 am]
BILLING CODE 4164-01-P
</pre></body>
</html>Indexed from Federal Register on August 12, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.